Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis

NCT00439543 is registered in ClinicalTrials.gov with Interstitial Lung Disease Study Group, Korea as lead sponsor.

NCT NCT00439543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00439543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
Lead sponsor
Interstitial Lung Disease Study Group, Korea
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 31, 2007
Completion date
August 31, 2007
Enrollment
15
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary fibrosis, pulmonary hypertension